Information
Imprimis NJOF Recalls Klarity-C Drops (Cyclosporine) 0.1%
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0157-2026Drug / Pharmaceutical
Imprimis NJOF Recalls Klarity-C Drops (Cyclosporine) 0.1%
Imprimis NJOF, LLC · Class III — Regulatory
Product Description
Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852, NDC 71384-514-05
Reason for Recall
Subpotent Drug
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
USA nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Imprimis NJOF, LLC initiated a Class III recall of a pharmaceutical product on October 20, 2025 affecting 67,091 bottles. Subpotent Drug. Class III recalls involve products that are unlikely to cause adverse health reactions but violate FDA regulations. The product was distributed in USA nationwide. Consumers may continue monitoring FDA updates regarding this recall.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.